"Cystatin C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES.
Concept/Terms
Cystatin C- Cystatin C
- gamma-Trace
- gamma Trace
- Post-gamma-Globulin
- Post gamma Globulin
- Cystatin 3
- Neuroendocrine Basic Polypeptide
- Basic Polypeptide, Neuroendocrine
Below are MeSH descriptors whose meaning is more general than "Cystatin C".
Below are MeSH descriptors whose meaning is more specific than "Cystatin C".
This graph shows the total number of publications written about "Cystatin C" by people in Harvard Catalyst Profiles by year, and whether "Cystatin C" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 8 | 8 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 4 | 4 |
| 2008 | 2 | 12 | 14 |
| 2009 | 5 | 5 | 10 |
| 2010 | 2 | 9 | 11 |
| 2011 | 3 | 2 | 5 |
| 2012 | 4 | 7 | 11 |
| 2013 | 10 | 4 | 14 |
| 2014 | 3 | 1 | 4 |
| 2015 | 5 | 7 | 12 |
| 2016 | 3 | 6 | 9 |
| 2017 | 4 | 3 | 7 |
| 2018 | 4 | 3 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 4 | 5 | 9 |
| 2022 | 2 | 3 | 5 |
| 2023 | 2 | 8 | 10 |
Below are the most recent publications written about "Cystatin C" by people in Profiles.
-
CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults. J Am Soc Nephrol. 2023 12 01; 34(12):1953-1964.
-
Genome-wide association analysis of cystatin-C kidney function in continental Africa. EBioMedicine. 2023 Sep; 95:104775.
-
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care. J Appl Lab Med. 2023 07 05; 8(4):789-816.
-
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer. JAMA Netw Open. 2023 07 03; 6(7):e2321715.
-
Transcriptome- and proteome-wide association studies nominate determinants of kidney function and damage. Genome Biol. 2023 06 26; 24(1):150.
-
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. Eur Heart J. 2023 06 25; 44(24):2202-2212.
-
Incremental prognostic value of biomarkers in PARADIGM-HF. Eur J Heart Fail. 2023 08; 25(8):1406-1414.
-
Estimating kidney function in patients with cancer: A narrative review. Acta Physiol (Oxf). 2023 06; 238(2):e13977.
-
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations. J Am Soc Nephrol. 2023 07 01; 34(7):1241-1251.
-
Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans. Front Endocrinol (Lausanne). 2023; 14:1081741.